European Journal of Translational Myology,
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 18, 2023
At
the
end
of
2023
Padua
Days
Muscle
and
Mobility
Medicine
next
year's
meeting
was
scheduled
from
27
February
to
2
March
2024
(2024Pdm3).
During
summer
autumn
program
confirmed
with
Scientific
Sessions
that
will
take
place
over
five
days,
starting
in
afternoon
27,
at
Conference
Room
Hotel
Petrarca,
Thermae
Euganean
Hills
(Padua),
Italy.
As
usual,
day
be
spent
Padua,
this
occasion
San
Luca
Hall
Santa
Giustina
monastery
Prato
della
Valle,
Collected
during
Autumn
2023,
many
more
titles
abstracts
than
expected
were
submitted,
forcing
organization
parallel
sessions
both
on
1
confirming
attractiveness
Pdm3.
The
days
include
oral
presentations
scientists
clinicians
Argentina,
Austria,
Belgium,
Brazil,
Canada,
Denmark,
Egypt,
France,
Germany,
Iceland,
Ireland,
Italy,
Romania,
Russia,
Slovenia,
Switzerland,
UK
USA.
Together
preliminary
Program
December
1,
early
submitted
Abstracts
is
e-published
Issue
33
(4)
European
Journal
Translational
Myology
(EJTM).
You
are
invited
join,
submitting
your
Last
Minute
[email protected]
by
2024.
Furthermore,
generous
deadline
May
20,
2024,
submit
please
“Communications”
(Clarivate’s
ESCI
Impact
factor
2.2;
SCOPUS
Cite
Score:
3.2).
See
you
soon
Petrarca
Montegrotto
Terme,
but
complete
can
followed
home
via
zoom
connection.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(18), С. 13835 - 13835
Опубликована: Сен. 8, 2023
Mitophagy
is
crucial
for
maintaining
mitochondrial
quality.
However,
its
assessment
in
vivo
challenging.
The
endosomal-lysosomal
system
a
more
accessible
pathway
through
which
subtypes
of
extracellular
vesicles
(EVs),
also
contain
constituents,
are
released
disposal.
inclusion
components
into
EVs
occurs
the
setting
mild
damage
and
during
impairment
lysosomal
function.
By
releasing
mitochondrial-derived
(MDVs),
cells
limit
unload
damage-associated
molecular
patterns
with
proinflammatory
activity.
Both
positive
negative
effects
on
recipient
have
been
described.
Whether
this
due
to
production
other
than
those
containing
mitochondria,
such
as
MDVs,
holding
specific
biological
functions
currently
unknown.
Evidence
existence
different
MDV
has
produced.
their
characterization
not
always
pursued,
would
be
relevant
exploring
dynamics
quality
control
health
disease.
Furthermore,
classification
may
instrumental
understanding
roles
promoting
implementation
biomarkers
clinical
studies.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(4), С. 2052 - 2052
Опубликована: Фев. 8, 2024
Sarcopenia,
the
age-associated
decline
in
skeletal
muscle
mass
and
strength,
is
a
condition
with
complex
pathophysiology.
Among
factors
underlying
development
of
sarcopenia
are
progressive
demise
motor
neurons,
transition
from
fast
to
slow
myosin
isoform
(type
II
type
I
fiber
switch),
decrease
satellite
cell
number
function.
Mitochondrial
dysfunction
has
been
indicated
as
key
contributor
myocyte
loss
physical
performance
aging.
Several
systems
have
implicated
regulation
plasticity
trophism
such
fine-tuned
between
stimulator
protein
synthesis,
mechanistic
target
rapamycin
(mTOR),
inhibitor
mTOR,
AMP-activated
kinase
(AMPK),
that
promotes
catabolism.
Here,
we
provide
an
overview
molecular
mechanisms
linking
mitochondrial
signaling
quality
homeostasis
discuss
main
pathways
elicited
by
their
imbalance
during
age-related
wasting.
We
also
lifestyle
interventions
(i.e.,
exercise
nutrition)
may
be
exploited
preserve
function
aged
muscle.
Finally,
illustrate
emerging
possibility
rescuing
tissue
through
transplantation.
Biomolecules,
Год журнала:
2024,
Номер
14(4), С. 415 - 415
Опубликована: Март 28, 2024
Sarcopenia
has
a
complex
pathophysiology
that
encompasses
metabolic
dysregulation
and
muscle
ultrastructural
changes.
Among
the
drivers
of
intracellular
changes
fibers
in
sarcopenia,
mitochondria
their
quality
control
pathways
play
relevant
roles.
Mononucleated
stem
cells/satellite
cells
(MSCs)
have
been
attributed
critical
role
repair
after
an
injury.
The
involvement
supporting
MSC-directed
is
unclear.
There
evidence
reduction
mitochondrial
biogenesis
blunts
repair,
thus
indicating
delivery
functional
to
injured
muscles
can
be
harnessed
limit
fibrosis
enhance
restoration
function.
Injection
autologous
respiration-competent
from
uninjured
sites
damaged
tissue
shown
reduce
infarct
size
cell
survival
preclinical
models
ischemia-reperfusion.
Furthermore,
incorporation
donor
into
MSCs
enhances
lung
cardiac
repair.
This
strategy
also
tested
for
regeneration
purposes
traumatic
injuries.
Indeed,
systemic
promotes
restores
mass
function
while
reducing
during
recovery
In
this
review,
we
discuss
contribution
altered
MSC
sarcopenia
illustrate
prospect
harnessing
as
therapeutic
against
age-related
sarcopenia.
Pharmacological Research,
Год журнала:
2024,
Номер
209, С. 107468 - 107468
Опубликована: Окт. 18, 2024
Myocardial
infarction
(MI)
remains
a
leading
cause
of
mortality
worldwide.
Despite
patients
with
MI
benefit
from
timely
reperfusion
therapies,
the
rates
and
morbidity
remain
substantial,
suggesting
an
enduring
need
for
development
new
approaches.
Molecular
mechanisms
underlying
myocardial
ischemic
injury
are
associated
both
cardiomyocytes
non-cardiomyocytes.
Exosomes
nano-sized
extracellular
vesicles
released
by
almost
all
eukaryotic
cells.
They
facilitate
communication
between
various
cells
transferring
information
via
their
cargo
altering
different
biological
activities
in
recipient
Studies
have
created
great
prospects
therapeutic
applications
exosomes
MI,
as
demonstrated
through
beneficial
effect
on
heart
function
reducing
ventricular
remodeling
association
fibrosis,
angiogenesis,
apoptosis,
inflammation.
Of
note,
is
primarily
due
to
restricted
blood
flow,
oxygen
availability,
causing
inefficient
utilization
energy
substrates.
However,
impact
cardiac
metabolism
has
not
been
adequately
investigated.
Although
engineered
targeted
delivery
enhance
clinical
efficacy,
challenges
must
be
overcome
utilize
them
reliably
clinic.
In
this
review,
we
summarize
research
progress
focus
known
unknown
regarding
role
non-cardiomyocytes;
well
potential
avenues
exosome-mitochondrial
regulation
challenges.
We
aim
help
identify
more
efficient
molecular
targets
that
may
promote
application
exosomes.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(2), С. 1175 - 1175
Опубликована: Янв. 18, 2024
Mitochondria
are
double-membrane
organelles
that
involved
in
energy
production,
apoptosis,
and
signaling
eukaryotic
cells.
Several
studies
conducted
over
the
past
decades
have
correlated
mitochondrial
dysfunction
with
various
diseases,
including
cerebral
ischemia,
myocardial
ischemia-reperfusion,
cancer.
Mitochondrial
transplantation
entails
importing
intact
mitochondria
from
healthy
tissues
into
diseased
damaged
to
rescue
injured
In
this
review,
different
techniques
their
clinical
applications
been
discussed.
addition,
challenges
future
directions
pertaining
its
potential
treatment
of
diseases
defective
summarized.
Aging and Disease,
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 1, 2024
Aging
is
an
inevitable
and
complex
biological
process
involving
multi-factorial
mechanisms.
Mitochondrial
dysfunction
a
critical
factor
in
the
aging
process,
characterized
by
decline
mitochondrial
quality
activity,
leading
to
aging-related
diseases.
Therefore,
mitochondria
have
become
attractive
target
anti-aging
therapies.
Several
senolytic
drugs
targeting
antioxidant
agents
been
used
research
past
few
years.
However,
these
strategies
may
cause
adverse
effects
with
long-term
medication.
In
this
extensive
review,
we
propose
"mitochondrial
transplantation,"
which
transfers
healthy
from
donor
cells
recipient
replace
damaged
or
dysfunctional
mitochondria,
as
new
alternative
strategy
for
treating
aging-associated
introduce
contemporary
landscape
of
transplantation,
then
discuss
intensely
successful
applications
transplantation
therapy
diseases
such
neurodegenerative
diseases,
cardiovascular
aging,
reproductive
highlighting
its
translational
potential.
Finally,
summarize
prospect
challenges
opportunities
faces
therapy.
European Journal of Translational Myology,
Год журнала:
2024,
Номер
unknown
Опубликована: Фев. 2, 2024
During
the
2023
Padua
Days
on
Muscle
and
Mobility
Medicine
2024
meeting
was
scheduled
from
28
February
to
2
March
(2024Pdm3).
autumn
program
expanded
with
Scientific
Sessions
which
will
take
place
over
five
days
(in
this
includes
29),
starting
afternoon
of
27
in
Conference
Rooms
Hotel
Petrarca,
Thermae
Euganean
Hills
(Padua),
Italy.
As
per
consolidated
tradition,
second
day
Padua,
for
occasion
Sala
San
Luca
Monastery
Santa
Giustina
Prato
della
Valle,
Confirming
attractiveness
Medicine,
100
titles
were
accepted
until
15
December
(many
more
than
expected),
forcing
organization
parallel
sessions
both
1
2024.
The
include
lectures
oral
presentations
scientists
clinicians
Argentina,
Austria,
Belgium,
Brazil,
Bulgaria,
Canada,
Denmark,
Egypt,
France,
Germany,
Iceland,
Ireland,
Italy,
Romania,
Russia,
Slovenia,
Switzerland,
UK
USA.
Only
Australia,
China,
India
Japan
are
missing
edition.
But
we
confident
that
authors
those
countries
who
publish
articles
PAGEpress:
European
Journal
Translational
Myology
(EJTM:
2022
ESCI
Clarivate's
Impact
Factor:
2.2;
SCOPUS
Cite
Score:
3.2)
decide
join
us
coming
years.
Together
established
by
31
January
2024,
abstracts
circulate
during
only
electronic
version
EJTM
Issue
34
(1)
See
you
soon
person
at
Petrarca
Montegrotto
Terme,
inauguration
or
on-line
free
via
Zoom.
Send
your
email
address
if
not
traditional
participants
listed
Pdm3
books.
Journal of Translational Medicine,
Год журнала:
2024,
Номер
22(1)
Опубликована: Окт. 15, 2024
The
prevalence
of
age-related
degenerative
joint
diseases,
particularly
intervertebral
disc
degeneration
and
osteoarthritis,
is
increasing,
thereby
posing
significant
challenges
for
the
elderly
population.
Mitochondrial
dysfunction
a
critical
factor
in
etiology
progression
these
disorders.
Therapeutic
interventions
that
incorporate
mitochondrial
transplantation
exhibit
considerable
promise
by
increasing
numbers
improving
their
functionality.
Existing
evidence
suggests
exogenous
therapy
improves
clinical
outcomes
patients
with
diseases.
This
review
elucidates
abnormalities
associated
diseases
examines
mechanisms
intercellular
transfer
artificial
transplantation.
Furthermore,
therapeutic
strategies
are
synthesized,
concept
engineered
proposed.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 31, 2025
Abstract
While
mitochondria
are
known
to
be
essential
for
intracellular
energy
production
and
overall
function,
emerging
evidence
highlights
their
role
in
influencing
cell
behavior
through
mitochondrial
transfer.
This
phenomenon
provides
a
potential
basis
the
development
of
treatment
strategies
tissue
damage
degeneration.
study
aims
evaluate
whether
isolated
from
osteoblasts
can
promote
osteogenic
differentiation
mesenchymal
stem
cells
(MSCs).
Mitochondria
MSCs,
which
primarily
utilize
glycolysis,
compared
with
those
MG63
cells,
depend
on
oxidative
phosphorylation.
both
types
then
encapsulated
cationic
liposomes
transferred
impact
is
assessed.
delivery
MSCs
grown
two‐
three‐dimensional
cultures
results
increased
expression
markers,
including
Runt‐related
transcription
factor
2,
Osterix,
Osteopontin,
upregulation
genes
involved
Bone
morphogenetic
protein
2
signaling
calcium
import.
accompanied
by
influx
regulated
Wnt/β‐catenin
pathway.
Transplantation
spheroids
containing
MG63‐derived
bone
defect
animal
models
improves
regeneration.
The
suggest
that
effectively
guides
toward
osteogenesis,
paving
way
mitochondria‐transplantation
therapies.